Abayasekara D R, Sheldrick E L, Flick-Smith H C, Flint A P
Zoological Society of London, Institute of Zoology, Regent's Park, NW1 4RY, London.
Endocrine. 1995 Feb;3(2):151-8. doi: 10.1007/BF02990067.
PhosphoIipid/Ca(2+) -dependent protein kinase C (PKC) and oxytocin receptor were measured in sheep endometrial explants after culture for up to 96 h. Oxytocin receptor binding and PKC activity were reduced by up to 90% in explants exposed to recombinant ovine trophoblast interferon (rolFN-τ), recombinant bovine IFN-α(1) or ovine conceptus secretory proteins (a source of IFN-τ). Inhibition occurred in both caruncular and intercaruncular endometrium taken between days 7 and 10 of the oestrous cycle and in intercaruncular (but not caruncular) endometrium on day 6. Down-regulation of PKC by continued exposure of expiants to 4β-phorbol myristate acetate, or treatment with PKC inhibitors reduced both oxytocin receptor binding and PKC activity by up to 70%. Tyrosine kinase inhibitors were ineffective. Addition of oxytocin or progesterone, which reduce oxytocin receptor bindingin vivo, also lowered oxytocin receptor bindingin vitro in the absence of any effect on PKC. The data indicate that IFN-τ inhibits oxytocin receptor synthesis by a mechanism involving PKC inhibition, but that a non-PKC pathway also operates to control oxytocin receptor binding in non-pregnant animals. These conclusions were supported by measuring PKC activity and oxytocin receptor binding in endometrium without culture. Prolonged exposure of the endometrium to IFN-τin vivo may lead to PKC down regulation by a mechanism analogous to that involved in the action of continuous activation by agonist, and this may represent one function of the prolonged secretion of IFN-τ over a 10-day period in early pregnancy.
在培养长达96小时的绵羊子宫内膜外植体中检测了磷脂/钙离子依赖性蛋白激酶C(PKC)和催产素受体。暴露于重组羊滋养层干扰素(rolFN-τ)、重组牛干扰素-α(1)或羊孕体分泌蛋白(一种干扰素-τ来源)的外植体中,催产素受体结合和PKC活性降低了多达90%。抑制作用发生在发情周期第7至10天采集的肉阜和肉阜间子宫内膜中,以及第6天的肉阜间(而非肉阜)子宫内膜中。通过使外植体持续暴露于4β-佛波醇肉豆蔻酸酯乙酸盐或用PKC抑制剂处理来下调PKC,可使催产素受体结合和PKC活性降低多达70%。酪氨酸激酶抑制剂无效。添加催产素或孕酮(它们在体内会降低催产素受体结合),在体外也会降低催产素受体结合,而对PKC没有任何影响。数据表明,干扰素-τ通过一种涉及PKC抑制的机制抑制催产素受体合成,但在未怀孕动物中,一条非PKC途径也参与控制催产素受体结合。在未培养的子宫内膜中测量PKC活性和催产素受体结合,支持了这些结论。子宫内膜在体内长时间暴露于干扰素-τ可能通过一种类似于激动剂持续激活作用所涉及的机制导致PKC下调,这可能代表了怀孕早期干扰素-τ在10天内持续分泌的一种功能。